Company / Accounts Receivable
CVS Health Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$39.8B
FY2025
5-year range
$24.4B / $39.8B
FY2021-FY2025
Trend
+9.1%
vs FY2024
Sector context
#1 of 137
Health Care
What the data says
Among 137 Health Care companies, CVS Health is in the top 1% for accounts receivable. Accounts Receivable has increased for 9 consecutive years, from $12.2B in FY2016 to $39.8B in FY2025.
Based on SEC 10-K filings.
$39.8B in FY2025 with a 5-year CAGR of +12.8%. Ranks 1st among 137 companies in Health Care.
Improved from $35.2B to $39.8B over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +13.4%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 137This company $39.8B Sector average $1.3B
▼
+2890.7% above sector average
Key checks
Key Insights
- CVS Health's accounts receivable has grown for 9 consecutive years.
- 5-year CAGR of +12.8%, indicating consistent growth.
- In FY2025, accounts receivable increased 9.1% year-over-year.
- Ranks #1 out of 137 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.8B | +9.1% |
| FY2024 | $36.5B | +3.5% |
| FY2023 | $35.2B | +29.2% |
| FY2022 | $27.3B | +11.6% |
| FY2021 | $24.4B | +12.4% |
| FY2020 | $21.7B | +10.8% |
| FY2019 | $19.6B | +11.3% |
| FY2018 | $17.6B | +33.8% |
| FY2017 | $13.2B | +8.4% |
| FY2016 | $12.2B | +2.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026